Fingerprint
Dive into the research topics of 'Brentuximab vedotin for the treatment of CD30+ lymphomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Brentuximab vedotin for the treatment of CD30+ lymphomas
Kelley V. Foyil, Nancy L. Bartlett
Research output: Contribution to journal › Review article › peer-review
33
Scopus
citations